Paragon Bioservices Revenue and Competitors
Estimated Revenue & Valuation
- Paragon Bioservices's estimated annual revenue is currently $12.6M per year.
- Paragon Bioservices received $5.0M in venture funding in August 2018.
- Paragon Bioservices's estimated revenue per employee is $155,000
- Paragon Bioservices's total funding is $20M.
Employee Data
- Paragon Bioservices has 81 Employees.
- Paragon Bioservices grew their employee count by -13% last year.
Paragon Bioservices's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
Paragon Bioservices Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Paragon Bioservices?
Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon's aim is to build strong client partnerships with the world's best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic protein, and other complex biologics.
keywords:Biotechnology,Healthcare,Pharmaceuticals
$20M
Total Funding
81
Number of Employees
$12.6M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Paragon Bioservices News
The growth of the Bioservices market was mainly driven by the ... Inc, Ology Bioservices, Inc., Paragon Gene Therapy, Park Bioservices,...
... Maryland (added through the 2019 acquisition of Paragon Bioservices), ploughed $100 million into its Anagni, Italy fill-finish facility...
Paragon Bioservices, APEX Biologix, VcanBio, Cryo-cell, Crioestaminal, LifeCell, ViaCord, Pepro Tech, Health Baby. Photo of Carl Allison Carl...
By April of 2019, Catalent had agreed to a $1.2 billion acquisition of gene therapy developer Paragon Bioservices. And most recently, the ...
Just this year, Catalent bought out California-based Paragon Bioservices? and Thermo Fisher Scientific acquired Brammer Bio?, located in ...
Other Companies in Baltimore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.7M | 81 | 40% | N/A |
#2 | $35M | 81 | 35% | N/A |
#3 | $14.6M | 81 | 8% | N/A |
#4 | $35M | 81 | 4% | N/A |
#5 | $23.5M | 81 | 27% | N/A |
Paragon Bioservices Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-10-29 | $13.0M | Undisclosed | NewSpring Capital | Article |
| 2015-08-21 | $2.0M | Undisclosed | Article | |
| 2018-08-14 | $5.0M | Undisclosed | Article |